DrugMay 8, 2019
Customceutical Compounding BPlex recall — FDA D-1254-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
Recall history in this database
Classification mix: Class II: 10.
DrugMay 8, 2019
Customceutical Compounding HCG recall — FDA D-1256-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Trimix HIGH recall — FDA D-1261-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding BPlex recall — FDA D-1253-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Test D recall — FDA D-1258-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Lipoplex recall — FDA D-1257-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL recall — FDA D-1255-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Test PROCYP recall — FDA D-1260-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding Test D recall — FDA D-1259-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
DrugMay 8, 2019
Customceutical Compounding TriMix MEDIUM recall — FDA D-1262-2019
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class IIFDA: TerminatedCustomceutical Compounding
Understanding this recall history
This page summarizes recall records in which the official source identifies Customceutical Compounding as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.